İndir Oncology Nursing Drug Handbook - v3.5.13

Tıp kategorisindeki en havalı Uygulamalar olan Oncology Nursing Drug Handbook - v3.5.13 veya X-RAY WOW, ALAT, Jan Aushadhi Sugam (BPPI), Pacify, Medical PG, FMGE Preparation - PrepLadder, Patchwork 'i duydunuz.

Ve tabii ki tüm oyunların veya uygulamaların tüm telefonlar için uyumlu olmadığını biliyorsunuz. Oyun veya uygulama bazen cihazınızda bulunmaz, sistemin sürümüne bağlıdır. Android işletim sistemi, ekran çözünürlüğü veya ülkeler Google Play'in erişime izin verdiği. Bu nedenle APKPanda, indirmeniz için Android APK dosyaları sağlar ve bu kısıtlamalara bağlı kalmaz.>
Oncology Nursing Drug Handbook - v3.5.13 en son sürüm 3.5.13, yayın tarihi 2020-06-25 ve 8.4 MB boyutuna sahip.Skyscape Medpresso Inc tarafından geliştirilmiştir, Oncology Nursing Drug Handbook - v3.5.13 en az Android sürümünü gerektirir Android 5.0+. Bu nedenle, gerekirse telefonunuzu güncellemelisiniz.

1000 indirme hakkında oldukça fazla yüklendi. İsterseniz Android cihazınıza tek tek indirilmiş veya yüklenmiş uygulamaları güncelleyebilirsiniz. Uygulamalarınızı güncellemek size en son özelliklere erişim izni verir ve uygulama güvenliğini ve kararlılığını artırır.

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity